380 related articles for article (PubMed ID: 30716510)
1. Intermittent PTH treatment improves bone and muscle in glucocorticoid treated Mdx mice: A model of Duchenne Muscular Dystrophy.
Yoon SH; Grynpas M; Mitchell J
Bone; 2019 Apr; 121():232-242. PubMed ID: 30716510
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment with Pamidronate Improves Bone Mechanical Properties in Mdx Mice Treated with Glucocorticoids.
Chen J; Yoon SH; Grynpas MD; Mitchell J
Calcif Tissue Int; 2019 Feb; 104(2):182-192. PubMed ID: 30302533
[TBL] [Abstract][Full Text] [Related]
3. Growth Hormone Increases Bone Toughness and Decreases Muscle Inflammation in Glucocorticoid-Treated Mdx Mice, Model of Duchenne Muscular Dystrophy.
Yoon SH; Grynpas MD; Mitchell J
J Bone Miner Res; 2019 Aug; 34(8):1473-1486. PubMed ID: 31188496
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic pamidronate partially protects from glucocorticoid-induced bone loss in the mdx mouse model of Duchenne muscular dystrophy.
Yoon SH; Chen J; Grynpas MD; Mitchell J
Bone; 2016 Sep; 90():168-80. PubMed ID: 27373502
[TBL] [Abstract][Full Text] [Related]
5. Effect of 25-HydroxyVitamin D Deficiency and Its Interaction with Prednisone Treatment on Musculoskeletal Health in Growing Mdx Mice.
Yoon SH; Sugamori KS; Grynpas MD; Mitchell J
Calcif Tissue Int; 2018 Sep; 103(3):311-323. PubMed ID: 29691609
[TBL] [Abstract][Full Text] [Related]
6. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.
Puolakkainen T; Ma H; Kainulainen H; Pasternack A; Rantalainen T; Ritvos O; Heikinheimo K; Hulmi JJ; Kiviranta R
BMC Musculoskelet Disord; 2017 Jan; 18(1):20. PubMed ID: 28103859
[TBL] [Abstract][Full Text] [Related]
7. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
8. Anti-RANKL Therapy Prevents Glucocorticoid-Induced Bone Loss and Promotes Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy.
Jayash SN; Hamoudi D; Stephen LA; Argaw A; Huesa C; Joseph S; Wong SC; Frenette J; Farquharson C
Calcif Tissue Int; 2023 Oct; 113(4):449-468. PubMed ID: 37470794
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
10. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
12. Black bear parathyroid hormone has greater anabolic effects on trabecular bone in dystrophin-deficient mice than in wild type mice.
Gray SK; McGee-Lawrence ME; Sanders JL; Condon KW; Tsai CJ; Donahue SW
Bone; 2012 Sep; 51(3):578-85. PubMed ID: 22584007
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
14. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
16. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
17. Molecular hydrogen alleviates motor deficits and muscle degeneration in mdx mice.
Hasegawa S; Ito M; Fukami M; Hashimoto M; Hirayama M; Ohno K
Redox Rep; 2017 Jan; 22(1):26-34. PubMed ID: 26866650
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy.
Nitahara-Kasahara Y; Nakayama S; Kimura K; Yamaguchi S; Kakiuchi Y; Nito C; Hayashi M; Nakaishi T; Ueda Y; Okada T
Stem Cell Res Ther; 2023 Apr; 14(1):108. PubMed ID: 37106393
[TBL] [Abstract][Full Text] [Related]
19. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
20. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
